{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T13:50:27Z","timestamp":1772200227611,"version":"3.50.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0186449","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T18:01:37Z","timestamp":1507831297000},"page":"e0186449","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3007-0387","authenticated-orcid":true,"given":"Xiaoxuan","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaowen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuren","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","article-title":"Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study","volume":"126","author":"M Lamberts","year":"2012","journal-title":"Circulation"},{"issue":"16","key":"ref2","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual, or triple therapywith warfarin, aspirin, and clopidogrel in patients with atrial fibrillation","volume":"170","author":"ML Hansen","year":"2010","journal-title":"Arch Intern Med"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2007.11.035","article-title":"Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis","volume":"51","author":"JM Ruiz-Nodar","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jacc.2016.05.085","article-title":"Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention","volume":"68","author":"NR Sutton","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"P Kirchhof","year":"2016","journal-title":"Europace"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00063-008-1101-4","article-title":"Anticoagulant and\/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience","volume":"103","author":"L Maegdefessel","year":"2008","journal-title":"Med Klin (Munich)"},{"issue":"9872","key":"ref7","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"WJ Dewilde","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"ref8","first-page":"234","article-title":"Balancing between bleeding and thromboembolism after percutaneous coronary intervention in patients with atrial fibrillation. Could triple anticoagulant therapy be a solution?","volume":"9","author":"M D\u0105browska","year":"2013","journal-title":"Postepy Kardiol Interwencyjnej"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2013.08.005","article-title":"Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy","volume":"166","author":"EL Fosbol","year":"2013","journal-title":"Am Heart J"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jjcc.2014.08.013","article-title":"Major bleeding complications related to combined antithrombotic therapy in atrial fibrillation patients 12 months after coronary artery stenting","volume":"65","author":"H Kawai","year":"2015","journal-title":"J Cardiol"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/clc.22254","article-title":"One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry","volume":"37","author":"A Rubboli","year":"2014","journal-title":"Clin Cardiol"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00380-013-0399-x","article-title":"Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation","volume":"29","author":"SY Suh","year":"2014","journal-title":"Heart Vessels"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/MCA.0000000000000242","article-title":"Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation","volume":"26","author":"DO Kang","year":"2015","journal-title":"Coron Artery Dis"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jacc.2015.05.062","article-title":"Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation","volume":"66","author":"CN Hess","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.amjcard.2015.03.033","article-title":"Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry)","volume":"116","author":"MG Mennuni","year":"2015","journal-title":"Am J Cardiol"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1253\/circj.CJ-15-0923","article-title":"Effects of Triple Therapy in Patients With Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Regarding Thromboembolic Risk Stratification","volume":"80","author":"A Sambola","year":"2016","journal-title":"Circ J"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"e0147245","DOI":"10.1371\/journal.pone.0147245","article-title":"Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention","volume":"11","author":"A Sambola","year":"2016","journal-title":"PLoS One"},{"issue":"16","key":"ref18","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.jcin.2016.05.039","article-title":"Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial","volume":"9","author":"MW Sherwood","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/CIRCULATIONAHA.116.025783","article-title":"Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy","volume":"135","author":"CM Gibson","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.14740\/jocmr2443w","article-title":"Clinical Relevance of Anticoagulation and Dual Antiplatelet Therapy to the Outcomes of Patients With Atrial Fibrillation and Recent Percutaneous Coronary Intervention With Stent","volume":"8","author":"R De Vecchis","year":"2016","journal-title":"J Clin Med Res"},{"issue":"7125","key":"ref21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/bmj.316.7125.140","article-title":"Spurious precision? Meta-analysis of observational studies","volume":"316","author":"M Egger","year":"1998","journal-title":"BMJ"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"152","author":"KF Schulz","year":"2010","journal-title":"Ann Intern Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration&apos;s tool for assessing risk of bias in randomised trials","volume":"343","author":"JP Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.76.1.142","article-title":"Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge","volume":"76","author":"JH Chesebro","year":"1987","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium","volume":"123","author":"R Mehran","year":"2011","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/sim.1201","article-title":"Network meta-analysis for indirect treatment comparisons","volume":"21","author":"T Lumley","year":"2002","journal-title":"Stat Med"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jtcvs.2016.07.044","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"152","author":"GN Levine","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"17","key":"ref28","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2146\/ajhp110556","article-title":"Triple antithrombotic therapy in patients with atrial fibrillation who have undergone percutaneous coronary intervention with stent implantation","volume":"69","author":"AR Barry","year":"2012","journal-title":"Am J Health Syst Pharm"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s00059-015-4325-0","article-title":"Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment. A meta-analysis","volume":"40","author":"CF Chen","year":"2015","journal-title":"Herz"},{"issue":"50","key":"ref30","doi-asserted-by":"crossref","first-page":"e5581","DOI":"10.1097\/MD.0000000000005581","article-title":"Comparing the clinical outcomes in patients with atrial fibrillation receiving dual antiplatelet therapy and patients receiving an addition of an anticoagulant after coronary stent implantation: A systematic review and meta-analysis of observational studies","volume":"95","author":"N Chaudhary","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2016.08.089","article-title":"Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary intervention","volume":"223","author":"M Kowalewski","year":"2016","journal-title":"Int J Cardiol"},{"issue":"25","key":"ref32","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI","volume":"375","author":"CM Gibson","year":"2016","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2013.02.036","article-title":"Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation","volume":"61","author":"N Sarafoff","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.jcin.2015.08.018","article-title":"Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study","volume":"8","author":"II Jackson LR","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"26","key":"ref35","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMoa0800374","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty","volume":"358","author":"BI Eriksson","year":"2008","journal-title":"N Engl J Med"},{"issue":"26","key":"ref36","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1056\/NEJMoa076016","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty","volume":"358","author":"MR Lassen","year":"2008","journal-title":"N Engl J Med"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"MR Patel","year":"2011","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0186449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T04:30:27Z","timestamp":1540355427000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0186449"}},"subtitle":[],"editor":[{"given":"Carmine","family":"Pizzi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,12]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0186449","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,12]]}}}